Pakke med 10 hætteglas6 på lagerSpar 25 %PT-141 10 mg
Bremelanotid melanocortinagonist
PT-141 bremelanotide research peptide, Australian-shipped. Lab-verified ≥99% purity.
Kun til forskningsbrug. Denne forbindelse sælges strengt til in vitro-forskning og laboratorieformål og er ikke beregnet til humant indtag eller terapeutisk brug. Ved køb bekræfter du, at du er en kvalificeret forsker og accepterer vores fulde ansvarsfraskrivelse.
Kun 6 pakker tilbage
Syntetisk melanocortinreceptoragonist undersøgt for virkninger på neurale veje forbundet med seksuel respons i forskningsanvendelser.
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist derived from the alpha-melanocyte-stimulating hormone (α-MSH) family. It is one of the most studied melanocortin-pathway research peptides outside of the tanning-active analogues. Quantum Labs supplies PT-141 as a lyophilised powder for Australian research applications.
Research on PT-141 has covered the central melanocortin pathway, particularly MC3R and MC4R receptor activation, and pre-clinical models of sexual-response signalling. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Mekanisme
Forskning tyder på primær agonisme af MC4R med virkninger i centralnervesystemet på neurokemiske markører hos studiedeltagere.
HPLC-verificeret mod en renhedsspecifikation på ≥99 %. Uafhængigt testet af akkrediterede tredjepartslaboratorier.
PT-141 — ofte stillede spørgsmål
What is PT-141?
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist studied in research models of central melanocortin-pathway signalling. It is one of the most-studied research peptides in the melanocortin family alongside the tanning-active analogues.
Is PT-141 legal in Australia?
PT-141 is restricted for compounded human therapeutic supply in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies PT-141 for research use only.
What receptors does PT-141 target?
PT-141 primarily activates the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors. Research has focused on the central melanocortin pathway, particularly downstream signalling in MC4R-rich brain regions.
What is bremelanotide?
Bremelanotide is the generic name for PT-141. It is a cyclic synthetic peptide derived from the α-MSH lineage. PT-141 is the research-code designation; bremelanotide is the pharmaceutical name.
What is the typical PT-141 research dosage?
Published research protocols have used wide dose ranges depending on the model and delivery route (intranasal, subcutaneous). Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.
Guides relateret til PT-141
Forskere udforsker også
UdvalgtPakke med 10 hætteglasSpar 17 %HGH
Lyofiliseret pulver10 IU · 4 strengths
Rekombinant humant væksthormon
I 2 stacks
Pakke med 10 hætteglasSpar 18 %Tesamorelin
Lyofiliseret pulver10 mg · 3 strengths
Stabiliseret GHRH-analog
I 1 stack
UdvalgtPakke med 10 hætteglasSpar 22 %CJC-1295 + Ipamorelin
Lyofiliseret pulver5 mg + 5 mg
Klassisk GHRH + ghrelinmimetisk stack
I 2 stacks